Transcriptional landscape of nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma: tumor microenvironment and checkpoint genes
Year: 2026
Type: article
Study design: Observational Study
Abstract: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare B-cell malignancy with an indolent course, yet some cases relapse or transform to Tcell/ histiocyte-rich large B-cell lymphoma (THRLBCL). Biological factors underlying poor outcomes in NLPHL are largely unknown, and the relationship between THRLBCL and untransformed NLPHL has not been systematically defined. We analyzed 178 NLPHL and 22 THRLBCL cases using whole-transcriptome RNA sequencing and clinical data. NLPHL patients were younger, had limited-stage disease, and better outcomes than THRLBCL patients. Variant immuno-architectural patterns (IAP) in NLPHL showed THRLBCL-like transcriptional profiles, especially with splenic involvement and high Lymphocyte-Predominant International Prognostic Score (LP-IPS). In-silico deconvolution of the tumor microenvironment (TME) revealed B-cell enrichment in classic NLPHL, intermediate profiles in variant NLPHL, and increased activated CD4+ and CD8+ T-cells and macrophages in THRLBCL. Higher follicular helper T-cell content was associated with shorter event-free survival in an exploratory analysis. NLPHL cases showed strong B-cell and T-helper signatures, whereas THRLBCL cases were enriched for macrophage and cytotoxic T-cell pathways and expressed higher immune checkpoint genes, suggesting an immunosuppressive TME. Signatures defined a spectrum from classic to variant NLPHL and THRLBCL. External validation in independent cohorts reproduced this gradient, supporting a continuous microenvironmental spectrum spanning NLPHL and THRLBCL.
Source: Haematologica
Authors: Ilja Kalashnikov, Veronica Russell, Rachel Kositsky, Leonardo P.A. Biral, Panu Kovanen, Johannes Dunkel, Marja-Liisa Karjalainen-Lindsberg, Annika Pasanen, Devang Thakkar, Jean L. Koff, David Jaye, Sarah Ondrejka, Eric D. Hsi, Emily F. Mason, Ridas Juskevicius, Cassandra Love, Jennifer R. Shingleton, Elizabeth Thacker, Lanie Happ, Clay Parker, Tushar Dave, Mette Ølgod Pedersen, Magdalena Czader, Jiehao Zhou, Dennis O'Malley, Mina Xu, Andrew Evans, Chee Leong Cheng, Matthew McKinney, Chad M. McCall, Eric Tse, Rex Au Yeung, Yasodha Natkunam, Abner Louissaint Jr., Jennifer Chapman, Catalina Amador, Amy Chadburn, Yuri Fedoriw, Amir Behdad, Carlos Galvez, Payal Sojitra, Andrew Evens, Kikkeri N Naresh, Sandeep S. Dave, Sirpa Leppä
Institutions: University of Helsinki, Helsinki University Hospital, Duke University, Emory University, Winship Cancer Institute, Cleveland Clinic, Mayo Clinic, Vanderbilt University Medical Center, University of Copenhagen, Zealand University Hospital, Indiana University Indianapolis, NeoGenomics (United States), Yale University, University of Rochester Medicine, University of Rochester, Singapore General Hospital, University of Hong Kong, Stanford Medicine, Massachusetts General Hospital, University of Miami, Sylvester Comprehensive Cancer Center, University of Nebraska at Omaha, Weill Cornell Medicine, University of North Carolina at Chapel Hill, Cleveland Clinic Florida, University of Illinois Chicago, Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Fred Hutch Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: nodular lymphocyte predominant Hodgkin lymphoma, T-cell/histiocyte-rich large B-cell lymphoma, lymphoma transformation, tumor microenvironment, immune checkpoint genes, immunosuppression, T follicular helper cells, macrophages, cytotoxic T lymphocytes, event-free survival, gene expression signatures, prognostic score
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W7225899857
